Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9641496rdf:typepubmed:Citationlld:pubmed
pubmed-article:9641496lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9641496lifeskim:mentionsumls-concept:C0030274lld:lifeskim
pubmed-article:9641496lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:9641496lifeskim:mentionsumls-concept:C0221198lld:lifeskim
pubmed-article:9641496lifeskim:mentionsumls-concept:C0334094lld:lifeskim
pubmed-article:9641496lifeskim:mentionsumls-concept:C0205234lld:lifeskim
pubmed-article:9641496pubmed:issue6lld:pubmed
pubmed-article:9641496pubmed:dateCreated1998-8-31lld:pubmed
pubmed-article:9641496pubmed:abstractTextThe K-ras gene is mutated in > or =75% of human pancreatic adenocarcinomas and in a number of hyperplastic ductal lesions from noncarcinoma patients. In this study, the incidence of K-ras mutation was determined in a spectrum of focal proliferative pancreatic lesions to evaluate their preneoplastic significance. PCR-based mutation-enriched RFLP analysis was used to identify mutations in codon 12. Immunostaining for Ki67 and p53 was also performed. Forty-seven % of intraductal nonpapillary hyperplasias (8 of 17) contained codon 12 mutations, as did 55% of adenomatoid hyperplasias (6 of 11). This rate increased to 61% in papillary hyperplasias (27 of 44) and to 78% when there was severe dysplasia (7 of 9). The fraction of cells staining for the Ki67 proliferation marker showed a general correlation with the rate of K-ras mutation. Nuclear staining for p53 protein was seen only in two ductal lesions with severe dysplasia. No mutations were found in normal acinar tissue (n = 38), squamous metaplasia (n = 13), ductal complexes (n = 8), or focal acinar cell dysplasia (n = 5). There seemed to be a general correlation of proliferative potential with the presence of K-ras mutation in ductal lesions. However, because of the high prevalence of lesions with K-ras mutations, we conclude that this mutation alone cannot be taken as proof of significant risk for progression to carcinoma. Efforts to use the presence of K-ras mutations in DNA harvested from pancreatic juice or duodenal aspirates as an approach for diagnosis of occult pancreatic carcinoma seem vulnerable to a high false-positive rate.lld:pubmed
pubmed-article:9641496pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9641496pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9641496pubmed:languageenglld:pubmed
pubmed-article:9641496pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9641496pubmed:citationSubsetIMlld:pubmed
pubmed-article:9641496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9641496pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9641496pubmed:statusMEDLINElld:pubmed
pubmed-article:9641496pubmed:monthJunlld:pubmed
pubmed-article:9641496pubmed:issn1055-9965lld:pubmed
pubmed-article:9641496pubmed:authorpubmed-author:LongneckerD...lld:pubmed
pubmed-article:9641496pubmed:authorpubmed-author:TostesonT DTDlld:pubmed
pubmed-article:9641496pubmed:authorpubmed-author:TerhuneP GPGlld:pubmed
pubmed-article:9641496pubmed:authorpubmed-author:PhiferD MDMlld:pubmed
pubmed-article:9641496pubmed:issnTypePrintlld:pubmed
pubmed-article:9641496pubmed:volume7lld:pubmed
pubmed-article:9641496pubmed:ownerNLMlld:pubmed
pubmed-article:9641496pubmed:authorsCompleteYlld:pubmed
pubmed-article:9641496pubmed:pagination515-21lld:pubmed
pubmed-article:9641496pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9641496pubmed:meshHeadingpubmed-meshheading:9641496-...lld:pubmed
pubmed-article:9641496pubmed:meshHeadingpubmed-meshheading:9641496-...lld:pubmed
pubmed-article:9641496pubmed:meshHeadingpubmed-meshheading:9641496-...lld:pubmed
pubmed-article:9641496pubmed:meshHeadingpubmed-meshheading:9641496-...lld:pubmed
pubmed-article:9641496pubmed:meshHeadingpubmed-meshheading:9641496-...lld:pubmed
pubmed-article:9641496pubmed:meshHeadingpubmed-meshheading:9641496-...lld:pubmed
pubmed-article:9641496pubmed:meshHeadingpubmed-meshheading:9641496-...lld:pubmed
pubmed-article:9641496pubmed:meshHeadingpubmed-meshheading:9641496-...lld:pubmed
pubmed-article:9641496pubmed:meshHeadingpubmed-meshheading:9641496-...lld:pubmed
pubmed-article:9641496pubmed:meshHeadingpubmed-meshheading:9641496-...lld:pubmed
pubmed-article:9641496pubmed:meshHeadingpubmed-meshheading:9641496-...lld:pubmed
pubmed-article:9641496pubmed:year1998lld:pubmed
pubmed-article:9641496pubmed:articleTitleK-ras mutation in focal proliferative lesions of human pancreas.lld:pubmed
pubmed-article:9641496pubmed:affiliationDepartment of Pathology, Dartmouth Medical School, Lebanon, New Hampshire 03756, USA.lld:pubmed
pubmed-article:9641496pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9641496pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9641496pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9641496lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9641496lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9641496lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9641496lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9641496lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9641496lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9641496lld:pubmed